Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Low HDL-C, uric acid, and 25-hydroxyvitamin D are risk factors for early-onset male hair loss.

Male pattern baldness in medical students is linked to higher depression, loneliness, and internet addiction.

Higher platelet counts and activators in PRP improve hair density and thickness in treating hair loss.

Microneedling with PRP is as effective and safe as minoxidil+finasteride for treating hair loss.

Testosterone causes hair loss in AGA mice, which are good for testing baldness treatments, and both minoxidil and cyproterone acetate can prevent this hair loss.

Follicular unit extraction is an effective and minimally invasive treatment for male hair loss.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Latanoprost can make eyelashes longer, thicker, and darker.

The document recommends using both clinical evaluation and various measurement methods to assess skin greasiness, considering factors like temperature and hormones.

Platelet-rich plasma may help with hair growth and skin quality but more research is needed to confirm its effectiveness.

Microneedling is a safe and effective treatment for various skin conditions, often preferred for its fewer side effects and shorter recovery time.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

Platelet preparations generally show positive effects on wound healing and facial rejuvenation, but more thorough research is needed to confirm their effectiveness.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

The document concludes that the effectiveness of platelet rich plasma in aesthetic surgery is unclear due to inconsistent reporting and lack of objective measures in studies.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Microneedling with platelet-rich plasma and minoxidil improves hair growth more than just minoxidil in men with hair loss.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Platelet-Rich Plasma (PRP) therapy can promote hair growth and improve facial aesthetics, including reducing acne scars and facial burns, and it works best with three initial monthly injections.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.

Scalp hair grows at 0.37 mm/day, forearm hair at 0.18 mm/day, and thigh hair at 0.30 mm/day, with no significant differences found in people with certain hair conditions.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

Understanding hair follicle biology and stem cell control could lead to new hair loss treatments.

Hair restoration surgery can lead to swelling, infections, scarring, numbness, hiccups, and poor hair growth.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

The document concludes that clinicians should be aware of common hair and scalp disorders in women of African descent and that more research is needed to develop effective treatments.

The document concludes that injecting platelet-rich plasma can effectively treat androgenetic alopecia, a type of hair loss.